Effectiveness of the Walking Intervention Walkadoo: A Randomized Controlled Pilot Trial in an Employee Population
Not Applicable
Completed
- Conditions
- Healthy
- Registration Number
- NCT02229409
- Lead Sponsor
- MeYou Health, LLC
- Brief Summary
This study evaluates the product Walkadoo to determine whether it effectively increases walking behavior in healthy adults.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 265
Inclusion Criteria
- Adults 18 years or older;
- Healthways employees based in Franklin, TN with an email account with the company;
- Provide informed consent and complete eligibility questionnaires
Exclusion Criteria
- Current or prior use of the intervention Walkadoo
- Presence of a chronic condition that affects walking
- Projected inability to access the internet for 4 consecutive days or longer during the study
- Non-adherence to device wear during baseline
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Average steps per day 6 weeks
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie increased walking behavior in healthy adults using Walkadoo?
How does Walkadoo compare to standard workplace wellness programs in promoting physical activity?
Are there specific biomarkers that predict adherence to walking interventions like Walkadoo?
What adverse events are associated with gamified walking interventions in employee populations?
What are the key features of Walkadoo that differentiate it from other digital health interventions for physical activity?
Trial Locations
- Locations (1)
MeYou Health
🇺🇸Boston, Massachusetts, United States
MeYou Health🇺🇸Boston, Massachusetts, United States